To study the cellular consequences of cohesin mutations in myeloid malignancies, we used CRISPR/Cas9 to engineer a spectrum of predicted LOF STAG2, SMC3, and RAD21 mutations identified in patients in AML cell lines WT for all cohesin subunits and modulators. Here, STAG2 is linked to acute myeloid leukemia.